Yolk-sac inoculation of embryonated eggs was superseded 25 years ago by the use of cell cultures (often McCoy) for the isolation of Chlamydia trachomatis. Centrifugation of specimens onto the cell monolayers was shown to increase sensitivity, but little of late has further improved sensitivity which is at least ten-fold greater than that of eggs. However, culture is slow and labour intensive so that non-cultural techniques without these drawbacks have come to dominate. Direct fluorescent antibody (DFA) tests are rapid and have sensitivities that range from 70% to 100% for men and 68% to 100% for women, and specificities that range from 87% to 99% for men and 82% to 100% for women; if the tests are read by competent observers the values are at the top end of the ranges. The detection rate may be enhanced even further by relatively low-speed centrifugation of specimens before staining. Skilled reading is not a feature of enzyme immunoassays (EIAs) which according to the literature have sensitivities that range from 62% to 97% for men and 64% to 100% for women, and specificities that range from 92% to 100% for men and 89% to 100% for women. However, comparison against poor reference tests is responsible for most of the higher values and the clinician should not be misled into believing that EIAs have excellent sensitivity; the lower values in the ranges are closer to reality. Furthermore, EIAs that are being designed for use by general practitioners should be regarded with the greatest caution since lack ofsensitivity means that chiamydiapositive patients will go undetected. The polymerase chain reaction (PCR) is not
bedeviled by insensitivity but it is no more sensitive than the most sensitive cell culture or DFA tests. PCR is unsuitable for routine diagnosis but has a place as a research tool. For men, examination of "first-catch" urine samples by the best of the non-cultural procedures provides an acceptable noninvasive approach to diagnosis; for women, the value of examining urine may be less, but needs to be thoroughly tested. However, there is little doubt that a Cytobrush used to obtain cervical specimens holds no practical advantage over a swab. Serological tests are reliant on the provision of paired sera for making a diagnosis; high antibody titres in single sera may be suggestive of an aetiological association in deep-seated chiamydial infections (epididymitis, arthritis, salpingitis, etc), but unequivocal interpretation is unusual, particularly in an individual case, since the distinction between a current and past infection is problematical.
Certain serovars of Chlamydia trachomatis, as the name implies, cause trachoma. The implication of other serovars in causing genital-tract disease and non-blinding paratrachoma has been reviewed recently.' The need for services to diagnose chlamydial infections in patients attending sexually transmitted disease (STD) clinics, particularly women, and to screen non-STD clinic populations is not in dispute. However, the development of such services is not helped by the fact that chlamydiae, despite being bacteria, behave like viruses in that they require viable cells in which to replicate. Any need for the regular use of cell cultures imposes limitations on organising an efficient country-wide diagnostic service and has given impetus to the development of techniques that are independent of cell culture. These have burgeoned but, as outlined, bring with them their own problems. The advantages and disadvantages of some or all of the techniques have been discussed recently"q and are presented in the table.
Collection, type and transport of specimens It should* not need stressing that the testing of a specimen that has been poorly taken and is 37 There is a wealth of information available for the MicroTrak test. This has been considered less sensitive than culture by some,"64' particularly for the detection of small numbers of organisms44 or in a low-prevalence population. 45 However, others4 47 found the method valuable in their low-prevalence populations and still others have found the method to be at least as sensitive as culture,4852 or almost so.5 '56 Examination of the literature reveals that the specificities of DFA tests have ranged from 87% to 99% for men and from 82% to 100% for women and the sensitivities from 70% to 100% for men and from 68% to 100% for women. Although the sensitivity values vary, excellent sensitivity in the hands of some should not come as a surprise. Indeed, it is easy to appreciate that if, in a DFA test single elementary bodies can be detected with confidence, the sensitivity of other procedures by comparison may be found wanting. However, the success ofthe DFA tests does, of course, depend on the experience of the observers,57 which includes the ability to detect small numbers of elementary bodies (< 10) and to discriminate between specific and non-specific staining.5859 In this regard, the staining of Gardnerella vaginalis (GL Ridgway and G Mumtaz, personal communication) and parainfluenza 2 virus particles' by chlamydial antibody should be noted. However, even for the moderately experienced observer, the morphological difference between chlamydial elementary bodies and other bacteria should make discrimination easy. Direct immunofluorescence, as exemplified by MicroTrak, has some special attributes. Its use has enabled chlamydiae to be detected in the joints of patients with sexually acquired reactive arthritis6' and, without question, it is more sensitive than culture for the detection of chlamydiae in endometrial or tubal specimens.6263 It has proved useful even for examining rectal specimens'M and has the potential for detecting chlamydiae in semen samples.65 It stands out as an easy way of testing single specimens and, together with other non-cultural techniques, has value in looking at specimens that have lost viable chlamydiae through prolonged transport'M or sub-optimal storage. Specimens that are toxic in cell culture may be looked at in a DFA test63 and, furthermore, the detection rate may be enhanced by relatively lowspeed centrifugation of specimens before staining.2' Direct immunofluorescence also may be used as a test ofcure. This is exemplified by the finding that all of30 chlamydia-positive non-gonococcal urethritis (NGU) patients had negative urethral tests 6-11 days after starting a course of tetracycline therapy. 67 However, a DFA test may remain positive after culture has suggested the disappearance of viable organisms. Thus, seven to ten days after 39 culturepositive women had completed doxycycline treatment (100 mg twice daily for seven days) and had become culture-negative, one of every five of them Surecell."2 These are simple to perform and, in effect, are "do-it-yourself' tests intended for clinicians to take up without resort to laboratory help. They may be useful in conjunctival infections"2 but, otherwise, clinicians will use them at their peril. The pitfalls inherent in any of the assays mentioned must apply to these too. DNA probes and the polymerase chain reaction (PCR) Palva et -all" were probably the first of several investigators to use DNA probes. They used chromosomal DNA, from the L2 serovar of C. trachomatis, digested with the restriction enzyme Bam H1 and cloned into E. coli by means of the plasmid vector pBr322. The probe behaved specifically in preliminary sandwich hybridisation tests and in tests on genital-tract specimens good sensitivity and moderately acceptable specificity (85%) were achieved."4 On the other hand, others"5 were less successful, particularly with specimens that were weakly positive in culture. Indeed, both false negative and false positive results were obtained. Since then impressions of the value of DNA probes have swayed back and forth. Dean et al,"6 screening a trachoma-endemic population, found that a probe based on a 7-0-kilobase cryptic plasmid from C. trachomatis had a sensitivity of 87% and a specificity of 91%, compared with culture; whether this is sufficiently sensitive is debatable. Certainly, others"7 118 found insufficient sensitivity to be a problem with the probes they used. A modification of the molecular probe is the use of luminescence."9 However, the Probe Assay Chemiluminescence Enhanced (PACE, Gen-Probe Inc.) test needs more detailed evaluation. In situ DNA hybridisation is another approach to the detection of C. trachomatis and has been used with cervical scrapings and rectal biopsies, the results apparently being more or less comparable with those obtained by culture. '20-23 The PCR is a new approach again, one that may leave other molecular tests behind. In allowing massive amplification of a DNA sequence, it has brought a hitherto unparalleled dimension to the problem of increasing sensitivity. '27 found that the PCR had high specificity and sensitivity; the latter workers, however, found that it was no more, and no less, sensitive than the MicroTrak DFA test when used-to test specimens from men with NGU. This, coupled with the ease with which contamination with DNA can occur in the laboratory, unless the most stringent precautions are taken to prevent it, suggest that the PCR is unlikely to find widespread use in routine diagnosis. The occurrence of false positive results will remain a worry. Nevertheless, it would seem that the PCR has considerable potential as a research tool, for example as a means of confirming the existence or otherwise of chlamydiae in arthritic joints when other methods (enzyme immunoassay, culture) fail, and for examining specimens that are limited in quantity.
Detection of antibody Various serological techniques have been used to study chlamydial infections. Complement fixation usually is not sufficiently sensitive to detect antibodies stimulated by uncomplicated genital infections, but has an acceptable place in the diagnosis of lymphogranuloma venereum infections and psittacosis.128 Immunofluorescence (IMF) and enzyme immunoassays,129130 including a 4-capture ELISA for chlamydia-specific IgM, "' are much more useful for all aspects of serology. Furthermore, immunoblotting has been used quite widely to correlate structure with function, in other words to determine which chlamydial antigens stimulate antibody production."3"
In considering the various clinical problems, several points emerge. Chlamydial antibody may not develop in about a fifth of men with acute NGU, the titres when measurable are usually quite low and it is rare to detect an antibody response. Indeed, there is no sense in attempting to make a diagnosis of chlamydial NGU on the basis of serology. The latter has been suggested as a complementary test'35 but its dubious value indicates that it should not be used even in this role.
In the case of epididymitis, patients who were culture positive (urethra and/or epididymal aspirate) in one study"l always had IgG IMF antibody titres equal to or greater than 1:64, whereas those who were culture negative had lower antibody titres. While these data are more convincing than those presented by Kaneti et al,"7 diagnosing a current infection in an individual patient on the basis of a single antibody titre cannot be guaranteed. The contention by Kojima et all' that antibody in semen is diagnostic needs further support. In the case of patients with sexually acquired reactive arthritis (SARA) (usually men), chlamydial serum antibody titres tend to be higher than those in patients with uncomplicated NGU or other arthritides."9 However, the titres overlap so that, again, a serological diagnosis of current infection on the basis ofa single serum titre is only suggestive and not foolproof. The possibility that antibody titres in synovial fluids of SARA patients sometimes might be higher than those in the corresponding sera, indicating local production and another way of associating organism with disease, requires further exploration.
The occurrence of serum antibodies frequently in women in whom chlamydiae cannot be detected in the cervix or elsewhere illustrates the problems encountered in using serology for diagnostic purposes. Although the antibody titres tend to be higher in women with cervical infections than in men with NGU, it is rare to see a rising titre and, if nothing else, wasteful ofresources to attempt to make a diagnosis of a cervical infection in this way or, indeed, on the presence of antibody in local secretions.'4" The detection of a rising antibody titre in pelvic inflammatory disease (PID) is uncommon but the titres tend to be higher in cases of PID than in uncomplicated cervical infections, and perhaps suggestive of an aetiological association if very high, an IMF titre of 1: > 512 being used by Kristensen et al. ' The majority seem not to favour this view and few of those who do present evidence. This might suggest that chlamydial infection in the asymptomatic patient is no more difficult to diagnose than in the symptomatic one, but it remains a moot point. In contrast, there seems to be no dissention from the view that for a test of moderate sensitivity and relatively high specificity (which most EIAs have), the predictive value of a positive result will be acceptable in a high prevalence population but will become unacceptable in a low prevalence one. This means that in a low risk population there may be more false positive than true positive results. The notion, however, that a low risk population contains relatively more individuals with a small number of organisms is often expressed39 162 but is questionable since it is supported only by weak evidence"s'; if infection occurs in a low risk group, there seems no reason why it should not run the same course and cause as much shedding as in a high risk group. It has to be understood, however, that even in a high risk group, small numbers of chlamydiae occur in about 40% of the population.'63 It is these that tend not to be detected by relatively insensitive methods, such as the EIAs, but only by the DFA tests and by the PCR. That is not to say that DFA tests do not have their problems. The number of elementary bodies used as the criterion of a positive result is still a contentious issue; the more that are used, the less sensitive the test. Furthermore, mis-reading may sometimes come to light only when the result seems quite unreasonable, as, for example, the claim of a high chlamydial prevalence rate for glue ear"s 165; by the same token, a detection rate of 40% in NGU, by its mere reasonableness, might hide the fact that the wrong patients were being regarded as chlamydia-positive. Advances will be made only if DFA tests can be automated and the PCR is endowed with mechanisms that can be guaranteed to prevent DNA contamination. Such tests ofhigh sensitivity that can be widely and easily used are needed urgently if all the chlamydia-positive patients in high risk groups are to be identified; at the moment many are not. Conversely, tests with exquisite specificity are needed for low risk groups to avoid large numbers of unnecessary and damaging false positive results.
It goes without saying that the most sensitive laboratory tests cannot overcome the deficit incurred by specimens being collected, transported or stored poorly. Assuming that this is not the case, chlamydial detection may be improved even further by taking multiple specimens; there are probably no microbiological situations where this does not apply.
However, reason has to prevail, particularly when obtaining specimens from the male urethra; the fact that urine is proving to be as satisfactory as a swab is helpful in this regard. What the results of detection mean once obtained is probably more in the province of the clinician than the laboratory worker. However, it is worth saying that interpretation depends on the clinical situation and type of specimen. Thus, detection of chlamydiae in the cervix of a woman who complains of lower abdominal pain is likely to mean that the organisms have entered the upper genital tract, irrespective of whether laparoscopy reveals abnormal fallopian tubes.63 On the other hand, the detection of chlamydiae in expressed prostatic secretion does not necessarily mean that the prostate is involved,"6 despite protestations to the contrary. '67 Finally, it has become a ritual to say that serological procedures offer little in the way ofmaking an accurate chlamydial diagnosis. Hopefully the day will come when antigens responsible for antibodies occurring in current and past infections will be cloned and expressed by molecular techniques and used to develop specific serology so that it does not remain enigmatic.
